Moneycontrol PRO
you are here: HomeNews
india covid 19
Jump to
  • India reports 2,527 fresh COVID-19 cases, 33 fatalities in last 24 hours Apr 23, 2022 10:15 AM IST

    India reports 2,527 fresh COVID-19 cases, 33 fatalities in last 24 hours

    The death toll has climbed to 5,22,149 with 33 fatalities, the data updated at 8 am stated.

  • Johns Hopkins Bloomberg School's Brian Wahl talks about preparedness of COVID third wave, the R factor, the Delta variant and more Jul 29, 2021 11:51 AM IST

    Johns Hopkins Bloomberg School's Brian Wahl talks about preparedness of COVID third wave, the R factor, the Delta variant and more

    The health epidemiologist says most models suggest a third wave, if there is one, would not be as intense as the second wave. But he also warns of potential emergence of a new variant that could better evade the immune system

  • Finance minister says no plan to print currency to tide over COVID-19 crisis Jul 26, 2021 01:25 PM IST

    Finance minister says no plan to print currency to tide over COVID-19 crisis

    FM Nirmala Sitharaman said the gradual scaling back of lockdowns, along with the astute support of Aatmanirbhar Bharat Mission has placed the economy firmly on the path of recovery from the second half of FY21.

  • 135 crore doses to be available between August and December, Rs 9,725 crore spent on vaccination: Govt tells Rahul Gandhi Jul 23, 2021 01:54 PM IST

    135 crore doses to be available between August and December, Rs 9,725 crore spent on vaccination: Govt tells Rahul Gandhi

    Over 41 lakh extra vaccine doses extracted, expected that beneficiaries aged 18 years and above will be vaccinated by December 2021, no fixed timeline at present can be indicated for completion of vaccination exercise, the government said to a question posed by Congress MP Rahul Gandhi in Lok Sabha.

  • Glove industry gains as demand surges due to COVID-19 Jun 30, 2021 05:37 PM IST

    Glove industry gains as demand surges due to COVID-19

    It has increased three times over the normal consumption, but manufactures are unable to meet the requirement as it is difficult to raise capacity in a short time; There are 28 glove manufacturing units in India, half of which are in Kerala

  • Record COVID-19 vaccinations on June 21: Which demographic got the most jabs? Jun 22, 2021 01:24 PM IST

    Record COVID-19 vaccinations on June 21: Which demographic got the most jabs?

    The 18-44 age group accounted for 72 percent of the nearly 86 lakh jabs given in all on Monday, official government data showed

  • 5 top experts weigh in on the possibility of a Third Wave, COVID-inappropriate behaviour and vaccination Jun 21, 2021 11:59 AM IST

    5 top experts weigh in on the possibility of a Third Wave, COVID-inappropriate behaviour and vaccination

    There have been enough warnings and road maps laid down on how to stockpile medical infrastructure. This, coupled with months of experience by the government and public alike on how to handle a pandemic, is ideal learning ground. If still the country fails now, it will be difficult to find scapegoats

  • Rural COVID-19 warriors up in arms; fixed wage less than Rs 100 a day Jun 18, 2021 12:42 PM IST

    Rural COVID-19 warriors up in arms; fixed wage less than Rs 100 a day

    An army of overworked and underpaid women is the backbone of the fight against the pandemic in rural areas. These unsung heroes are not given protective gear and paid a pittance

  • RDIF says Sputnik V will soon offer booster shot that's adjusted to work against Delta variant Jun 17, 2021 06:24 PM IST

    RDIF says Sputnik V will soon offer booster shot that's adjusted to work against Delta variant

    Sputnik V uses heterogeneous boosting with 2 shots by 2 different adenoviral vectors Ad5 and Ad26. The adenoviral vector Ad26 is used for prime boost, and Ad5 is used as booster dose. RDIF didn't clarify which vector it would be adjusting against Delta variant.

  • Did coronavirus originate in a Wuhan lab? Clamour grows for China to offer answers Jun 15, 2021 05:01 PM IST

    Did coronavirus originate in a Wuhan lab? Clamour grows for China to offer answers

    Over the past few weeks, statements from the White House and the G7 have spurred renewed interest on how SARS-CoV-2, the virus that causes COVID-19, may have developed. Here's a breakdown of the various theories, including the one that it leaked from a Wuhan lab.

  • Delivery by Drones: Vaccines may reach remote areas starting in August Jun 15, 2021 11:25 AM IST

    Delivery by Drones: Vaccines may reach remote areas starting in August

    Telangana and Maharashtra may become the first two states to start using drones to deliver vaccines, while 20 entities have been selected to conduct trials

  • Economic impact of second wave will not be as severe as the first: Finance Secretary Jun 10, 2021 03:12 PM IST

    Economic impact of second wave will not be as severe as the first: Finance Secretary

    The pace of vaccination holds the key to the momentum and sustainability of the economic recovery.

  • Private hospitals look to renegotiate deals with vaccine companies Jun 10, 2021 11:03 AM IST

    Private hospitals look to renegotiate deals with vaccine companies

    With limits on purchases and the prices they can charge, private hospitals are assessing the impact on their COVID-19 vaccination drives

  • Big lesson from Covid is that India must abandon the US healthcare model: Jean Dreze Jun 04, 2021 01:31 PM IST

    Big lesson from Covid is that India must abandon the US healthcare model: Jean Dreze

    Jean Dreze, the Belgian-born hunger economics expert, on the devastation of Covid, what plagues MNREGA, central government’s relief measures, stimulus packages, vaccination drive and more.

  • COVID-19 impact – delayed payments, less work pushes up MNREGA needs; raise total spends up to Rs 1.3 lakh crore, say activists May 27, 2021 03:06 PM IST

    COVID-19 impact – delayed payments, less work pushes up MNREGA needs; raise total spends up to Rs 1.3 lakh crore, say activists

    As the infection spreads to India's interior, livelihood loss is a double-edged sword: migrant workers losing jobs in cities are returning to their homes and need alternate sources of earning; campaigners demand tripling wages

  • COVID-19 | Govt now prefers rapid antigen tests to RT-PCR to contain virus in rural areas May 21, 2021 12:41 PM IST

    COVID-19 | Govt now prefers rapid antigen tests to RT-PCR to contain virus in rural areas

    The spread of COVID-19 to rural areas has forced the government to make a U-turn on the testing strategy

  • MBBS students, fresh graduates fill gaps in COVID wards, but there are challenges May 20, 2021 04:50 PM IST

    MBBS students, fresh graduates fill gaps in COVID wards, but there are challenges

    Hospitals are deploying medicine students and freshly graduated doctors for COVID care, but many complain of long hours and delayed salaries at government facilities, while senior physicians get the additional burden of training raw talent.

  • Global bids for over 21 crore COVID-19 vaccine doses floated by States, but do not get your hopes too high May 20, 2021 12:10 PM IST

    Global bids for over 21 crore COVID-19 vaccine doses floated by States, but do not get your hopes too high

    States are under pressure as jabs for 18-44 age group amongst daily vaccinations is now as high as 44 percent

  • How India’s vaccination drive could play out with the available shots May 19, 2021 05:37 PM IST

    How India’s vaccination drive could play out with the available shots

    By August, suggest some experts, the situation will ease. July is the crucial month when indigenous production of vaccines will go up, as will imports

  • Gagandeep Kang backs 12-week interval for second dose of Covishield, says move based on real-world data May 18, 2021 12:31 PM IST

    Gagandeep Kang backs 12-week interval for second dose of Covishield, says move based on real-world data

    One of India's top virologists Dr Gagandeep Kang spoke to Moneycontrol about her expectations on the trajectory of the current wave of COVID-19, the government's vaccine policy, and how India should prepare for a third wave.

  • COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered May 06, 2021 11:27 AM IST

    COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered

    What does the US decision to support an initiative at WTO for temporary waiver of patent protection for COVID-19 vaccines mean for India? Below is a primer.

  • Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts May 05, 2021 12:43 PM IST

    Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

    Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

  • 3 top doctors weigh on the second wave of the virus, limited lockdowns and what next Apr 27, 2021 12:40 PM IST

    3 top doctors weigh on the second wave of the virus, limited lockdowns and what next

    Medical experts remain divided on when the Second Wave is going to peak and how long it could take to subside

  • In Pics | COVID-19 outbreak - A look at worst-hit states in India Jun 02, 2020 12:56 PM IST

    In Pics | COVID-19 outbreak - A look at worst-hit states in India

    The government is taking all precautionary measures to stem the spread of the deadly virus.

  • Nifty up 20% from March low when COVID-19 cases were 500; what is driving rally? Apr 13, 2020 04:49 PM IST

    Nifty up 20% from March low when COVID-19 cases were 500; what is driving rally?

    The Nifty index has rallied by about 20 percent to hit 9,000 levels as on April 13 while a multi-fold increase was seen in COVID-19 related cases.

Sections
ISO 27001 - BSI Assurance Mark